Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Dec 12, 2018
Date Accepted: Dec 12, 2018
Date Submitted to PubMed: Feb 6, 2019

The final, peer-reviewed published version of this preprint can be found here:

Corrigendum and Editorial Warning Regarding Use of the MMAS-8 Scale (A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study)

Hale TM, Jethwani K, Kandola MS, Saldana F, Kvedar JC

Corrigendum and Editorial Warning Regarding Use of the MMAS-8 Scale (A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study)

J Med Internet Res 2019;21(2):e13125

DOI: 10.2196/13125

PMID: 30721131

PMCID: 6379813

Correction: A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study

  • Timothy M. Hale; 
  • Kamal Jethwani; 
  • Manjinder Singh Kandola; 
  • Fidencio Saldana; 
  • Joseph C Kvedar

 Citation

Please cite as:

Hale TM, Jethwani K, Kandola MS, Saldana F, Kvedar JC

Corrigendum and Editorial Warning Regarding Use of the MMAS-8 Scale (A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study)

J Med Internet Res 2019;21(2):e13125

DOI: 10.2196/13125

PMID: 30721131

PMCID: 6379813

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.